Business Wire (Free subscription) | yesterday
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting
Market Watch (Free subscription) | 22/09/2008
Most drug stocks are marginally lower, but shares of AstraZeneca PLC climb in the wake of a series of stock repurchases.
Market Watch (Free subscription) | 22/09/2008
BOSTON (MarketWatch) -- Drug stocks traded marginally lower early Monday while shares of AstraZeneca PLC climbed in the wake of a series of stock repurchases. The Amex Pharmaceutical Index was down nominally at 298.0 and the Amex Biotechnology Index dipped 0.5% to 804.7. U.K. drugmaker AstraZeneca was the big winner amongst the large cap issues, with shares up over 3% at $46.65. The company repurchased...
Chicago Tribune (Free subscription) | 06/09/2008
Medications cited for potential safety problems Eli Lilly & Co.'s antidepressant Cymbalta and AstraZeneca PLC's antipsychotic Seroquel are among 20 drugs cited by U.S. regulators in their first quarterly list of medicines under investigation for potential safety problems.
Business Wire (Free subscription) | 19/08/2008
EXTON, Pa.--(BUSINESS WIRE)--Melior Discovery, Inc. announced today that it has signed an agreement with AstraZeneca PLC under which Melior’s in-vivo
Market Wire (Free subscription) | 12/08/2008
LONDON, UNITED KINGDOM (MARKET WIRE) Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.
Mistaken Phil (Free subscription) | 15/07/2008
Time for a quick look at another FTSE100 constituent. And, for once, an interesting one! AstraZeneca (AZN) is a large, diversified pharmaceutical company. The market cap. is about £34 Billion, the yield is about 4% and the PE about 10. AZN markets a bewildering array of drugs, some of which are growing some of which are not. The number of drugs on its books makes it hard to analyse but does lower the...
Market Watch (Free subscription) | 09/07/2008
BOSTON (MarketWatch) -- European drugmakers led drug stocks northward, with AstraZeneca PLC , GlaxoSmithKline PLC , Novartis AG and Novo Nordisk A/S gaining the most ground. The Amex Pharmaceutical Index edged up 0.4% to 306.8 and the Amex Biotechnology Index eased 0.4% to 767.9. Novo Nordisk shares were the highest climbers, up 3% at $65.16. Market Pulse Stories are Rapid-fire, short news bursts...
Inbox Robot: Swiss Reinsurance News (Free subscription) | 02/07/2008
Astra shares up 6 pct on Seroquel court ruling (AP) LONDON - Shares in AstraZeneca PLC jumped 6 percent Wednesday after the drug maker won a
Inbox Robot: Swiss Reinsurance News (Free subscription) | 02/07/2008
LONDON (AP) - Shares in AstraZeneca PLC jumped 6 percent on Wednesday after the drug maker won a key patent battle in the United States over
Market Watch (Free subscription) | 02/07/2008
BOSTON (MarketWatch)-- Drug stocks edged higher in early action Wednesday as shares of AstraZeneca PLC gained on news that it had won a significant court decision that should help ward off generic competition for its drug Seroquel in the U.S. until around 2011. The Amex Pharmaceutical Index and the Amex Biotechnology Index were both up marginally at 293.4 and 750.0, respectively. AstraZeneca shares...
Seattle Times (Free subscription) | 02/07/2008
Shares in AstraZeneca PLC jumped 6 percent Wednesday after the drug maker won a key patent battle in the United States over Seroquel, its anti-psychotic drug and second-best seller.
kansascity.com (Free subscription) | 02/07/2008
Shares in AstraZeneca PLC jumped 6 percent Wednesday after the drug maker won a key patent battle in the United States over Seroquel, its anti-psychotic drug and second-best seller.
San Fransisco Chronicle (Free subscription) | 02/07/2008
Shares in AstraZeneca PLC jumped 6 percent Wednesday after the drug maker won a key patent battle in the United States over Seroquel, its anti-psychotic drug and second-best seller. The decision by a U.S. court to award a summary judgment in AstraZeneca's...
The Washington Times (Free subscription) | 02/07/2008
Shares in AstraZeneca PLC jumped 6 percent Wednesday after the drug maker won a key patent battle in the United States over Seroquel, its anti-psychotic drug and second-best seller.
